These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 30870056)

  • 1. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
    Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
    Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
    Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
    Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
    Petsuksiri J; Sermsree A; Thephamongkhol K; Keskool P; Thongyai K; Chansilpa Y; Pattaranutaporn P
    Radiat Oncol; 2011 Feb; 6():19. PubMed ID: 21333025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
    BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma.
    Su SF; Huang Y; Xiao WW; Huang SM; Han F; Xie CM; Lu TX
    Radiother Oncol; 2012 Sep; 104(3):312-6. PubMed ID: 22857858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
    Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution and Dosimetric Analysis of Magnetic Resonance Imaging-Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
    Huang XD; Li YC; Chen FP; Zheng WH; Zhou GQ; Lin L; Hu J; He WJ; Zhang LL; Kou J; Ma J; Zhang WD; Qi ZY; Sun Y
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):124-131. PubMed ID: 31075310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
    Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
    Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
    Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
    Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
    Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy-induced ear toxicity.
    Jereczek-Fossa BA; Zarowski A; Milani F; Orecchia R
    Cancer Treat Rev; 2003 Oct; 29(5):417-30. PubMed ID: 12972360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.
    Zhang LL; Wang XJ; Zhou GQ; Tang LL; Lin AH; Ma J; Sun Y
    Sci Rep; 2015 Dec; 5():18415. PubMed ID: 26678599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
    Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
    Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Lin L; Zhang WJ; Peng YL; Chen L; Tang LL; Mao YP; Ma J; Sun Y
    Sci Rep; 2015 Sep; 5():13525. PubMed ID: 26323586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and factors associated with sensorineural and conductive hearing loss among survivors of congenital diaphragmatic hernia.
    Partridge EA; Bridge C; Donaher JG; Herkert LM; Grill E; Danzer E; Gerdes M; Hoffman CH; D'Agostino JA; Bernbaum JC; Rintoul NE; Peranteau WH; Flake AW; Adzick NS; Hedrick HL
    J Pediatr Surg; 2014 Jun; 49(6):890-4; discussion 894. PubMed ID: 24888829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma.
    Wang J; Chen YY; Tai A; Chen XL; Huang SM; Yang C; Bao Y; Li NW; Deng XW; Zhao C; Chen M; Li XA
    Transl Oncol; 2015 Dec; 8(6):456-62. PubMed ID: 26692526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.